Skip to main content

Table 3 Assessments and outcomes during follow-up

From: Outcome of patients with double valve surgery between 2009 and 2018 at University Hospital Basel, Switzerland

 

DVR (N = 41)

AVR + MVP (N = 48)

p

Years of follow-up

4.6 [3.0 to 6.1]

4.5 [2.8 to 6.0]

0.65

Postoperative LVEF (%)

51 [40 to 60]

48 [40 to 55]

0.11

Three months LVEF %

46 [35 to 54]

48 [35 to 60]

0.56

Twelve months LVEF

42 [29 to 55]

54 [41 to 58]

0.45

Postoperative complications

7 (17%)

5 (10%

0.36

Rehospitalisation due to cardiac cause

3 (7%)

7 (14.5%)

0.28

Reoperation on aortic and/or mitral valves

2 (4.9%)

1 (2.0%)

0.47

Thirty days mortality

3 (7%)

3 (6.3%)

0.84

Thirty days mortality (excluding endocarditis)

2 (4.8%)

1 (2%)

0.46

Overall Death

7 (17%)

11 (23%)

0.60

Cause of death

  

1.00

Cardiovascular

1 (2.4%)

3 (6.3%)

 

Other

4 (10%)

5 (10%)

 

Unknown

2 (4.6%)

3 (6.3%)